Understanding Spravato (Esketamine): Is It Right for Treatment-Resistant Depression?

A general overview of what Spravato is and who it's typically considered for.

For people who have tried multiple antidepressants without relief, hearing the term 'treatment-resistant depression' can feel discouraging. Spravato (esketamine) is one of the newer options developed specifically for this situation, and it works differently than traditional antidepressants.

What Makes It Different

Most antidepressants target serotonin and can take several weeks to show effect. Spravato works on a different brain pathway (the glutamate system) and, for many patients, can begin easing depressive symptoms considerably faster than traditional medications.

Who It's Typically Considered For

Spravato is generally considered for adults with major depressive disorder who haven't responded adequately to at least two other antidepressant treatments. It's usually used alongside an oral antidepressant, not as a replacement.

What Treatment Looks Like

Because of how the medication is administered and monitored, treatment happens in-office under observation for a period after each dose. This isn't a take-home prescription — it's a structured, supervised process, which is part of why it requires a provider experienced in administering it.

Is It Right for You?

That's a conversation for you and your prescribing provider, based on your treatment history, other health considerations, and goals. If you've tried multiple medications without the relief you were hoping for, it's worth asking your provider whether Spravato might be an appropriate next step to discuss.